[Application and challenges of the new generation detection technologies in precision medicine for leukemia].
作者信息
Qin Y Z, Huang X J
机构信息
Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2019 May 14;40(5):353-357. doi: 10.3760/cma.j.issn.0253-2727.2019.05.001.
Abstract
摘要
相似文献
1
[Application and challenges of the new generation detection technologies in precision medicine for leukemia].新一代检测技术在白血病精准医学中的应用与挑战
Zhonghua Xue Ye Xue Za Zhi. 2019 May 14;40(5):353-357. doi: 10.3760/cma.j.issn.0253-2727.2019.05.001.
2
The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities.儿科急性淋巴细胞白血病的基因组图谱和精准医疗机会。
Semin Cancer Biol. 2022 Sep;84:144-152. doi: 10.1016/j.semcancer.2020.10.013. Epub 2020 Nov 13.
3
Application of High Throughput Technologies in the Development of Acute Myeloid Leukemia Therapy: Challenges and Progress.高通量技术在急性髓系白血病治疗开发中的应用：挑战与进展。
Int J Mol Sci. 2022 Mar 5;23(5):2863. doi: 10.3390/ijms23052863.
4
Scientific Achievements May Not Reach Everyone: Understanding Disparities in Acute Leukemia.科学成就可能无法惠及所有人：了解急性白血病方面的差异。
Curr Hematol Malig Rep. 2016 Aug;11(4):265-70. doi: 10.1007/s11899-016-0329-y.
5
Transcriptomics paving the way for improved diagnostics and precision medicine of acute leukemia.转录组学为急性白血病的诊断和精准医学铺平道路。
Semin Cancer Biol. 2022 Sep;84:40-49. doi: 10.1016/j.semcancer.2021.09.013. Epub 2021 Oct 1.
6
Precision Medicine and Precision Public Health in the Era of Pathogen Next-Generation Sequencing.病原体下一代测序时代的精准医学和精准公共卫生。
J Infect Dis. 2020 Mar 28;221(Suppl 3):S289-S291. doi: 10.1093/infdis/jiz424.
7
[Research on Precision Medicine, Gene Polymorphism, and Combination of Disease Identification and Syndrome Typing on Cardiovascular Diseases].[心血管疾病精准医学、基因多态性及病证结合研究]
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2016 Oct;36(10):1255-1260.
8
Driving Toward Precision Medicine for Acute Leukemias: Are We There Yet?为急性白血病精准医疗而努力：我们是否已经到达？
Pharmacotherapy. 2017 Sep;37(9):1052-1072. doi: 10.1002/phar.1977. Epub 2017 Jul 31.
9
[The promise of omics in the precision medicine era].[组学在精准医学时代的前景]
Rev Med Interne. 2022 Nov;43(11):649-660. doi: 10.1016/j.revmed.2022.07.009. Epub 2022 Aug 27.
10
The importance of precision medicine in modern molecular oncology.精准医学在现代分子肿瘤学中的重要性。
Clin Genet. 2021 Sep;100(3):248-257. doi: 10.1111/cge.13998. Epub 2021 Jun 2.
本文引用的文献
1
[Prognostic impact of circulating tumor DNA status post-allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndromes].[异基因造血干细胞移植后循环肿瘤DNA状态对急性髓系白血病和骨髓增生异常综合征的预后影响]
Rinsho Ketsueki. 2021;62(5):486-495. doi: 10.11406/rinketsu.62.486.
2
Genetics and prognosis of ALL in children vs adults.儿童与成人 ALL 的遗传学和预后。
Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):137-145. doi: 10.1182/asheducation-2018.1.137.
3
Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML.在 AML 患者进行异基因造血细胞移植前，通过 NGS 进行可测量残留病监测。
Blood. 2018 Oct 18;132(16):1703-1713. doi: 10.1182/blood-2018-02-829911. Epub 2018 Sep 6.
4
Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia.缓解期体细胞突变清除与急性髓系白血病复发风险
J Clin Oncol. 2018 Jun 20;36(18):1788-1797. doi: 10.1200/JCO.2017.77.6757. Epub 2018 Apr 27.
5
A next-generation sequencing-based assay for minimal residual disease assessment in AML patients with -ITD mutations.基于下一代测序的 AML 患者伴-ITD 突变微小残留病灶评估检测方法。
Blood Adv. 2018 Apr 24;2(8):825-831. doi: 10.1182/bloodadvances.2018015925.
6
Molecular Minimal Residual Disease in Acute Myeloid Leukemia.急性髓系白血病的分子微小残留病。
N Engl J Med. 2018 Mar 29;378(13):1189-1199. doi: 10.1056/NEJMoa1716863.
7
The TP53 Pro72Arg SNP in de novo acute myeloid leukemia.初发急性髓系白血病中的TP53 Pro72Arg单核苷酸多态性
Haematologica. 2017 May;102(5):e214-e215. doi: 10.3324/haematol.2017.165019.
8
Multicolor Flow Cytometry and Multigene Next-Generation Sequencing Are Complementary and Highly Predictive for Relapse in Acute Myeloid Leukemia after Allogeneic Transplantation.多色流式细胞术和多基因下一代测序对异基因移植后急性髓系白血病复发具有互补性且预测性很强。
Biol Blood Marrow Transplant. 2017 Jul;23(7):1064-1071. doi: 10.1016/j.bbmt.2017.03.017. Epub 2017 Mar 15.
9
The dynamics of RUNX1-RUNX1T1 transcript levels after allogeneic hematopoietic stem cell transplantation predict relapse in patients with t(8;21) acute myeloid leukemia.异基因造血干细胞移植后RUNX1-RUNX1T1转录水平的动态变化可预测t(8;21)急性髓系白血病患者的复发情况。
J Hematol Oncol. 2017 Feb 6;10(1):44. doi: 10.1186/s13045-017-0414-2.
10
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.成人急性髓系白血病的诊断与管理：2017年国际专家小组的欧洲白血病网络（ELN）建议
Blood. 2017 Jan 26;129(4):424-447. doi: 10.1182/blood-2016-08-733196. Epub 2016 Nov 28.
Zotero 插件